Full-Time

R&D Program Director

Posted on 5/11/2026

Philips

Philips

Healthcare technology for diagnosis, care, wellness

Compensation Overview

$172k - $292k/yr

+ Annual incentive bonus + Sales commission + Long-term incentives

No H1B Sponsorship

Wayzata, MN, USA + 1 more

More locations: San Diego, CA, USA

Hybrid

Three days on-site per week required for office-based teams.

Category
Biology & Biotech (1)
Requirements
  • Bachelor’s degree in engineering, science, or a related field; an advanced degree and/or program management certification is a plus
  • You’ve acquired 10+ years of experience leading complex product development programs, ideally involving capital equipment, medical devices, or other regulated hardware and software systems
  • Experience leading programs that combine hardware, electronics, software, systems integration, and launch execution, leading teams across multiple sites, functions, and stakeholders, and knowing how to create alignment in a matrixed, globally distributed environments
  • You must be able to successfully perform the following minimum Physical, Cognitive and Environmental job requirements with or without accommodation for this position
  • US work authorization is a precondition of employment
  • Company relocation benefits will not be provided for this position; you must reside in or within commuting distance to San Diego, CA or Plymouth, MN
Responsibilities
  • Lead a strategic console platform program spanning hardware, electronics, software, systems integration, regulatory readiness, manufacturing readiness, service readiness, and launch execution
  • Own the integrated end-to-end program plan across phased releases, connecting development, verification and validation, documentation, supply chain readiness, field readiness, and commercial launch activities
  • Drive alignment across a globally distributed team that includes engineering, quality, regulatory, operations, service, marketing, finance, and leadership stakeholders, ensuring clarity on priorities, dependencies, risks, decisions, and ownership
  • Partner with internal operations teams and external manufacturing partners to prepare product configurations for release, scale-up, and ongoing platform evolution
  • Lead formal design, business, and readiness reviews with strong preparation, concise communication, disciplined follow-through, and timely escalation of issues that threaten cost, quality, scope, or timing
  • Bring structure and execution rigor to a complex medical device platform program while improving cross-functional coordination, transparency, and decision making without adding unnecessary process burden
Desired Qualifications
  • Advanced degree and/or program management certification is a plus
  • Experience with regulated medical devices or similar regulated hardware and software systems is preferred
  • Experience leading programs across multiple sites and stakeholders in a matrixed global environment is preferable
  • Regulatory affairs experience or knowledge of regulatory readiness activities is desirable

Philips develops health technology across professional medical devices, connected care, and consumer health products. Its offerings include diagnostic imaging and image-guided therapy, patient monitoring and clinical informatics, and everyday wellness products like oral and personal care. The company increasingly delivers integrated solutions through a Healthcare-as-a-Service subscription model and long-term partnerships with hospitals and health systems. Its aim is to improve people’s health and well-being by making advanced health technology easier to access and integrate into care.

Company Size

N/A

Company Stage

IPO

Headquarters

Andover, Minnesota

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • Aims to improve 2.5 billion lives yearly by 2030 via partnerships.
  • Partnered with HealthAlliance Hospital for advanced imaging and monitoring.
  • Strong global presence in North America, Europe, and emerging markets.

What critics are saying

  • 2021 Respironics recall triggers ongoing lawsuits and erodes Connected Care trust.
  • GE HealthCare's AI MRI scanners outperform Philips in speed and quality.
  • $1.1 billion DreamStation settlement drains cash and deters HaaS deals.

What makes Philips unique

  • Philips segments into Diagnosis & Treatment, Connected Care, and Personal Health.
  • Shifting to Healthcare-as-a-Service model with subscription-based solutions.
  • Launched Shavetopia metaverse in Roblox for Movember men's health awareness.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

Parker Waichman LLP
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.

VentureBeat
Oct 26th, 2022
Philips Norelco Brings Movember To Roblox With Shavetopia

Register now for your free virtual pass to the Low-Code/No-Code Summit this November 9. Hear from executives from Service Now, Credit Karma, Stitch Fix, Appian, and more. Learn more. Philips Norelco is creating an interactive metaverse experience called Shavetopia in Roblox, based around the Movember trend. For anyone who doesn’t know what that is, Movember is where people grow facial hair for the entire month of November. The portmanteau comes from adding the word mustache to the name of the month